Barchart.com
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Sunshine Biopharma (SBFM)

Sunshine Biopharma (SBFM)
1.2400 +0.0200 (+1.64%) 14:07 ET [NASDAQ]
1.2200 x 2 1.2400 x 2
Realtime by (Cboe BZX)
1.2200 x 2 1.2400 x 2
Realtime 1.2200 unch (unch) 09:21 ET
News & Headlines for Thu, Apr 17th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering ACCESS Newswire - Thu Apr 3, 5:50AM CDT

FORT LAUDERDALE, FL / ACCESS Newswire / April 3, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic...

SBFM : 1.2360 (+1.31%)
Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules ACCESS Newswire - Wed Apr 2, 8:20AM CDT

FORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic...

SBFM : 1.2360 (+1.31%)
Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer ACCESS Newswire - Wed Apr 2, 3:00AM CDT

FORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) ("We", "Our", the "Company"), a pharmaceutical company offering and researching life-saving medicines in a...

SBFM : 1.2360 (+1.31%)
Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year ACCESS Newswire - Tue Apr 1, 12:09PM CDT

FORT LAUDERDALE, FL / ACCESS Newswire / April 1, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic...

SBFM : 1.2360 (+1.31%)
Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada ACCESS Newswire - Mon Mar 24, 3:00AM CDT

FORT LAUDERDALE, FL / ACCESS Newswire / March 24, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas...

SBFM : 1.2360 (+1.31%)
Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market ACCESS Newswire - Mon Mar 10, 4:00AM CDT

FORT LAUDERDALE, FL / ACCESS Newswire / March 10, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas...

SBFM : 1.2360 (+1.31%)
Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT ACCESS Newswire - Tue Jan 21, 2:00AM CST

FORT LAUDERDALE, FL / ACCESS Newswire / January 21, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of...

SBFM : 1.2360 (+1.31%)
Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer ACCESS Newswire - Wed Jan 15, 2:00AM CST

FORT LAUDERDALE, FL / ACCESSWIRE / January 15, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic...

SBFM : 1.2360 (+1.31%)
Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus ACCESS Newswire - Mon Dec 9, 2024

FORT LAUDERDALE, FL / ACCESSWIRE / December 9, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic...

SBFM : 1.2360 (+1.31%)
Sunshine Biopharma Launches a New Generic Prescription Drug ACCESS Newswire - Wed Dec 4, 2024

FORT LAUDERDALE, FL / ACCESSWIRE / December 4, 2024 / Sunshine Biopharma Inc. (NASDAQ:"SBFM") (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic...

SBFM : 1.2360 (+1.31%)
Sunshine Biopharma Announces Breakthrough Research Results on the Company’s K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma ACCESS Newswire - Mon Dec 2, 2024

FORT LAUDERDALE, FL / ACCESSWIRE / December 2, 2024 / Sunshine Biopharma Inc. (NASDAQ:"SBFM") (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic...

SBFM : 1.2360 (+1.31%)
Sunshine Biopharma Launches a New Generic Prescription Drug ACCESS Newswire - Fri Nov 22, 2024

FORT LAUDERDALE, FL / ACCESSWIRE / November 22, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic...

SBFM : 1.2360 (+1.31%)
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth FinancialNewsMedia - Wed Sep 4, 2024

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:NVAX),(NASDAQ:RGNX),(NASDAQ:BNTX),(NYSE:ABBV) EQNX::TICKER_END

SBFM : 1.2360 (+1.31%)
RGNX : 6.03 (-2.11%)
NVAX : 5.95 (-4.03%)
ABBV : 174.87 (+1.86%)
BNTX : 97.88 (-0.38%)
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth GlobeNewswire - Wed Sep 4, 2024

SBFM : 1.2360 (+1.31%)
RGNX : 6.03 (-2.11%)
NVAX : 5.95 (-4.03%)
ABBV : 174.87 (+1.86%)
BNTX : 97.88 (-0.38%)
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031 FinancialNewsMedia - Wed Sep 4, 2024

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NYSE:PFE),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END

SBFM : 1.2360 (+1.31%)
INO : 1.7400 (+1.16%)
MRNA : 24.77 (-1.67%)
PFE : 22.34 (+1.36%)
VIR : 5.45 (+0.37%)
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031 GlobeNewswire - Wed Sep 4, 2024

SBFM : 1.2360 (+1.31%)
INO : 1.7400 (+1.16%)
MRNA : 24.77 (-1.67%)
PFE : 22.34 (+1.36%)
VIR : 5.45 (+0.37%)
SUNSHINE BIOPHARMA ANNOUNCES PUBLICATION OF SIGNIFICANT CORONAVIRUS RESEARCH RESULTS IN THE JOURNAL OF MEDICINAL CHEMISTRY FinancialNewsMedia - Wed Sep 4, 2024

Current Test Positivity Rate for Coronavirus Infection in the U.S. is 18% Development of a novel antiviral compound, XR8-23 (Compound 10), targeting SARS-CoV-2 papain-like protease (PLpro) with both submicromolar...

SBFM : 1.2360 (+1.31%)
Coronavirus Vaccine Market To Surpass $95 Billion By 2028 FinancialNewsMedia - Tue Feb 28, 2023

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NASDAQ:NVAX),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END

SBFM : 1.2360 (+1.31%)
NVAX : 5.95 (-4.03%)
INO : 1.7400 (+1.16%)
MRNA : 24.77 (-1.67%)
VIR : 5.45 (+0.37%)
Coronavirus Vaccine Market To Surpass $95 Billion By 2028 PR Newswire - Tue Feb 28, 2023

/PRNewswire/ -- The Coronavirus Global Market has been growing in the past few years and is anticipated to continue to grow in the next several years. In fact,...

SBFM : 1.2360 (+1.31%)
NVAX : 5.95 (-4.03%)
INO : 1.7400 (+1.16%)
MRNA : 24.77 (-1.67%)
VIR : 5.45 (+0.37%)
SUNSHINE BIOPHARMA SIGNS EXCLUSIVE WORLDWIDE LICENSE WITH UNIVERSITY OF ARIZONA FOR PLpro-BASED COVID-19 TREATMENT FinancialNewsMedia - Tue Feb 28, 2023

Montreal – February 28, 2023 – Sunshine Biopharma Inc. (NASDAQ: SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and...

SBFM : 1.2360 (+1.31%)
One in Five Americans Who Have Been Infected With the Virus Said to Have Long COVID PR Newswire - Thu Nov 17, 2022

/PRNewswire/ -- Research and development is still focused on trying to help understand the acute infection 9itself and the effects of long COVID as well. As...

SBFM : 1.2360 (+1.31%)
RGNX : 6.03 (-2.11%)
ABBV : 174.87 (+1.86%)
OCEL : 2.7500 (unch)
RVNC : 3.65 (+0.27%)
One in Five Americans Who Have Been Infected With the Virus Said to Have Long COVID FinancialNewsMedia - Thu Nov 17, 2022

Palm Beach, FL – November 17, 2022 – FinancialNewsMedia.com News Commentary – Since the beginning of the pandemic, the critical effort of researchers is to understand how coronavirus damages the...

SBFM : 1.2360 (+1.31%)
RGNX : 6.03 (-2.11%)
ABBV : 174.87 (+1.86%)
OCEL : 2.7500 (unch)
RVNC : 3.65 (+0.27%)
Sunshine Biopharma Increases Support for Anti-Coronavirus Collaborative Research With the University of Arizona Globe Newswire - Thu Jul 28, 2022

MONTREAL, July 28, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM” and SBFMW) (the “Company” or “Sunshine Biopharma”), a pharmaceutical...

SBFM : 1.2360 (+1.31%)
SBFMW : 0.4100 (+86.36%)
Sunshine Biopharma, Inc. Announces Closing of $19.5 Million Private Placement Priced At-the-Market Globe Newswire - Thu Apr 28, 2022

MONTREAL, April 28, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a...

SBFM : 1.2360 (+1.31%)
SBFMW : 0.4100 (+86.36%)
Aegis Capital Corp. acted as Exclusive Placement Agent on a $19.5 Million Private Placement Priced At-the-Market for Sunshine Biopharma Inc. (NASDAQ: SBFM) ACCESS Newswire - Thu Apr 28, 2022

Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.

SBFM : 1.2360 (+1.31%)
Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-Market Globe Newswire - Mon Apr 25, 2022

MONTREAL, April 26, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a...

SBFM : 1.2360 (+1.31%)
SBFMW : 0.4100 (+86.36%)
Advanced Immunological and Clinical Trials for Treating Ovarian Cancer Accelerating FinancialNewsMedia - Mon Apr 25, 2022

Palm Beach, FL – April 25, 2022 – FinancialNewsMedia.com News Commentary – The formation of mutational cells or tissues in female reproductive organs called ovaries leads to ovarian cancer. Cancer...

SBFM : 1.2360 (+1.31%)
BVAXF : 0.0388 (+10.86%)
CTIC : 9.09 (unch)
BIOV.CN : 0.0500 (+11.11%)
IMGN : 31.23 (unch)
CLVS : 0.0812 (-5.58%)
Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer Cells Globe Newswire - Mon Apr 25, 2022

MONTREAL, April 25, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”), a pharmaceutical company focused on the research,...

SBFM : 1.2360 (+1.31%)
SBFMW : 0.4100 (+86.36%)
Aegis Capital Corp. acted as Exclusive Placement Agent on an $8 Million Private Placement for Sunshine Biopharma Inc. (NASDAQ: SBFM) ACCESS Newswire - Tue Mar 15, 2022

NEW YORK, NY / ACCESSWIRE / March 15, 2022 / Aegis Capital Corp. acted as Exclusive Placement Agent on an $8 Million Private Placement for Sunshine Biopharma Inc. (NASDAQ:SBFM) About Sunshine Biopharma,...

SBFM : 1.2360 (+1.31%)
Sunshine Biopharma, Inc. Announces Closing of $8.0 Million Private Placement Priced At-the-Market Globe Newswire - Mon Mar 14, 2022

MONTREAL, March 14, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a...

SBFM : 1.2360 (+1.31%)
SBFMW : 0.4100 (+86.36%)

Barchart Exclusives

Apple Was the Top Smartphone Seller in Q1. Does That Make AAPL Stock a Buy Here? Barchart - 3 minutes ago
The global smartphone market grew 3% in Q1, with Apple claiming the top spot despite challenges in developed markets. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro
Wed, Apr 23, 2025 5:00 PM UTC
Reserve Your Spot